In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events: Release of stock exchange notification. Press release, quarterly ...

The goal of conducting a fast-tracked nuclear test can only be political, not scientific. The United States has much to lose ...

The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.

Diverse Applications: FAPI-based radiotracers have shown promising results in diagnosing various cancers, particularly gastrointestinal malignancies, and have potential applications in inflammatory ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

This study utilizes bibliometric analysis to investigate the research landscape of FAP-directed cancer theranostics, focusing ...

AdvanCell is developing therapies to treat cancers including: prostate, skin, pancreatic, breast, bladder, colorectal, kidney ...

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...

"One advantage of the shallow entry, slow velocity atmospheric path model is that by the time the meteoroid is close to ...

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...